VentiRx Pharmaceuticals' Unattributed VC Round

VentiRx Pharmaceuticals raised a round of funding on June 11, 2008.

VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cance…

Articles about VentiRx Pharmaceuticals' Unattributed VC Round: